Home / Guides / Regulatory affairs
Regulatory affairs course
Regulatory affairs is the work of preparing and tracking the documents a regulator asks for, before a company studies a medicine and again before it sells one.
What regulatory affairs is
A regulator decides whether a study may start and, later, whether a product may be sold. The company sends a file that says what the product is, how it was made, and what the studies showed. Regulatory affairs is the group that builds and maintains that file.
Names differ by country. An IND or a clinical trial application asks to study a product in people. An NDA, a marketing authorisation application, or an ANDA asks to sell it. The Common Technical Document, the CTD, is the folder structure ICH regions use so the same science can be read in a shared order. eCTD is that folder in electronic form.
None of those abbreviations is a promise that one course files a real dossier. They are the map of the work.
Roles
A regulatory associate tracks submissions, publishing, and the questions a reviewer sends back. Other people specialise in labelling, in chemistry and manufacturing (often called CMC), or in the clinical part of the file. A local affiliate may adapt a global file to one country's form.
The PharmaWiz regulatory affairs page calls the training part of ASCEND, with mentor Ameeroddin Mohammad. The curriculum headings include an introduction to regulatory affairs, clinical trials and phases, drug discovery and development, dosage forms, ICH quality guidelines, scale-up, IND, NDA, MAA and ANDA, and CTD and eCTD modules.
Skills
The skill is reading a regulation closely enough to know which document it wants, and writing so a reviewer can find the answer. People also learn the product lifecycle: discovery, the trial phases, approval, and the changes that need a new filing after approval.
A pharmacy degree helps with dosage forms, specifications and manufacturing language. The regulations themselves still have to be learned country by country.
Career path
Associates often start in publishing and document control, then take a section of a submission. Later work can be strategy: which study to run, or how to answer a deficiency letter. Labelling and CMC are sideways moves, not a single sequence.
Teams exist in pharmaceutical companies, in firms that write files for them, and inside regulators. A course can teach the vocabulary. It does not confer the right to sign a submission.
How to start
Learn the stages of development and the difference between a trial application and a marketing application. Skim the five modules of the CTD so you know where quality, nonclinical and clinical reports sit. Then take a class that walks those documents in order.
PharmaWiz teaches the published courses at KPHB Phase-I, Road No. 1, Kukatpally, Hyderabad, or live on Microsoft Teams. ASCEND, the programme those courses sit inside, is 4 months and 120 hours. Eligibility on the regulatory affairs page is B.Pharm, M.Pharm, Pharm D and life sciences graduates. The certificate line is a PharmaWiz certificate.
Questions
What is a regulatory affairs course?
It is training in how a company prepares the documents a regulator reads, from the trial application through the marketing file and later changes. The PharmaWiz page lists those topics inside ASCEND.
What is the CTD?
The Common Technical Document is the ICH folder structure for a marketing application. eCTD is the electronic version. Module 3 is quality, module 4 is nonclinical, and module 5 is clinical.
Does PharmaWiz teach regulatory affairs in Hyderabad?
Yes. The class is at KPHB, Kukatpally, Hyderabad, or live on Microsoft Teams. Ameeroddin Mohammad is the mentor named on the course page.
Who can join?
The course page says B.Pharm, M.Pharm, Pharm D and life sciences graduates.
